DRUG AND BIOTECH STOCKS | January 16, 2006 Issue - Vol. 84 Issue 3 | Chemical & Engineering News
Volume 84 Issue 3 | p. 19
Issue Date: January 16, 2006

DRUG AND BIOTECH STOCKS

Drug company stock performance was bested by biopharmaceuticals'
Department: Business | Collection: Economy

 

FOURTH-QUARTER STOCK PRICEa

CHANGE FROM THIRD-QUARTER CLOSE

CHANGE FROM 2004 CLOSE PRICE/ EARNINGS RATIOb
  HIGH LOW CLOSE
MAJOR PHARMACEUTICAL COMPANIES
Abbott Laboratories $44.01 $37.63 $39.43 -7.0% -14.7% 16
Baxter International 40.04 36.59 37.65 -5.6 9.2 19
Bristol-Myers Squibb 23.95 21.03 22.98 -4.5 -9.7 15
Eli Lilly & Co. 57.81 49.76 56.59 5.7 1.3 20
Johnson & Johnson 64.32 60.04 60.10 -5.0 -5.0 17
Merck 32.35 25.85 31.81 16.9 0.7 13
Pfizer 25.29 20.60 23.32 -6.6 -12.8 11
Schering-Plough 21.76 19.05 20.85 -1.0 1.1 74
Wyeth 47.48 41.20 46.07 -0.4 8.9 16
C&EN pharmaceutical indexc (1992 = 100) 354.4 330.1 347.5 -1.1% -2.2%  
Dow Jones industrial average 10931.6 10215.2 10717.5 1.4% -0.6%  
BIOPHARMACEUTICAL AND DRUG DISCOVERY COMPANIES
Amgen $84.42 $73.37 $78.86 -1.0% 23.2% 26
Biogen Idec 45.52 35.94 45.28 14.7 -33.0 32
Celera Genomics 12.92 10.51 10.96 -9.6 -19.3 def
Cephalon 65.28 43.73 64.74 39.5 26.7 22
Chiron 44.85 43.00 44.44 1.8 33.4 97
Cytogen 3.95 2.74 2.74 -32.2 -75.6 def
Genentech 99.66 81.15 92.50 9.8 69.1 80
Genzyme 77.53 67.46 70.78 -1.2 22.8 32
Gilead Sciences 55.63 45.21 52.57 7.8 51.0 38
Icos 30.18 25.38 27.63 0.0 -1.1 def
MedImmune 37.06 32.14 35.02 4.1 29.3 152
Millennium Pharmaceuticals 10.92 8.09 9.70 4.0 -19.3 def
Protein Design Labs 29.92 25.49 28.42 1.5 39.4 def
Vertex Pharmaceuticals 28.92 20.79 27.67 23.8 160.0 def
Xoma 1.83 1.46 1.60 -9.1 -36.7 def
C&EN biopharmaceutical indexd (1992 = 100) 581.7 500.4 567.4 7.3% 21.3%  
NASDAQ 2273.4 2037.5 2205.3 2.5% 2.0%  

a Adjusted for stock splits. b As of Dec. 30, 2005. c Based on the average stock price for the nine drugcompanies listed. d Based on the average stock pricefor the 15 biopharmaceutical companies listed. def = deficit in previous four quarters.


MORE ON THIS STORY

Stock Indexes Mixed

Chemicals and biotech improve in fourth quarter, but pharmaceuticals decline slightly

 

TABLE 1 - CHEMICAL STOCKS

Some chemical stock prices suffer big declines

 

TABLE 2 - DRUG AND BIOTECH STOCKS

Drug company stock performance was bested by biopharmaceuticals'


 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment